Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.

Saved in:
Bibliographic Details
Title: Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
Authors: Iwama, E.1,2, Sakai, K.3, Azuma, K.4, Harada, T.2, Harada, D.5, Nosaki, K.6, Hotta, K.7, Ohyanagi, F.8, Kurata, T.9, Fukuhara, T.10, Akamatsu, H.11, Goto, K.12, Shimose, T.13, Kishimoto, J.14, Nakanishi, Y.2, Nishio, K.3, Okamoto, I.2 okamotoi@kokyu.med.kyushu-u.ac.jp
Source: Annals of Oncology. Jan2017, Vol. 28 Issue 1, p136-141. 6p. 1 Chart, 2 Graphs.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first